Will AI replace Regulatory Submissions Specialist jobs in 2026? High Risk risk (67%)
AI is poised to significantly impact Regulatory Submissions Specialists by automating routine tasks such as data entry, document formatting, and literature reviews. Large Language Models (LLMs) can assist in generating summaries and drafting sections of regulatory documents, while robotic process automation (RPA) can streamline submission processes. However, tasks requiring critical thinking, strategic planning, and direct interaction with regulatory agencies will remain human-centric.
According to displacement.ai, Regulatory Submissions Specialist faces a 67% AI displacement risk score, with significant impact expected within 5-10 years.
Source: displacement.ai/jobs/regulatory-submissions-specialist — Updated February 2026
The pharmaceutical and biotech industries are increasingly adopting AI to accelerate drug development and streamline regulatory processes. This includes using AI for data analysis, predictive modeling, and automated report generation, leading to increased efficiency and reduced costs.
Get weekly displacement risk updates and alerts when scores change.
Join 2,000+ professionals staying ahead of AI disruption
LLMs can assist in drafting sections of submissions and RPA can automate data compilation, but human oversight is needed for accuracy and strategic decision-making.
Expected: 5-10 years
AI-powered tools can monitor regulatory changes and provide summaries, but human expertise is needed to interpret and apply these changes.
Expected: 2-5 years
AI can assist in data analysis and pattern recognition, but human judgment is crucial for interpreting complex scientific data and ensuring compliance.
Expected: 5-10 years
Requires nuanced communication and relationship-building skills that are difficult for AI to replicate.
Expected: 10+ years
LLMs can generate drafts of SOPs and RPA can automate document management.
Expected: 2-5 years
RPA and AI-powered project management tools can automate tracking and reporting.
Expected: 2-5 years
Tools and courses to strengthen your career resilience
Some links are affiliate links. We only recommend tools we believe help with career resilience.
Common questions about AI and regulatory submissions specialist careers
According to displacement.ai analysis, Regulatory Submissions Specialist has a 67% AI displacement risk, which is considered high risk. AI is poised to significantly impact Regulatory Submissions Specialists by automating routine tasks such as data entry, document formatting, and literature reviews. Large Language Models (LLMs) can assist in generating summaries and drafting sections of regulatory documents, while robotic process automation (RPA) can streamline submission processes. However, tasks requiring critical thinking, strategic planning, and direct interaction with regulatory agencies will remain human-centric. The timeline for significant impact is 5-10 years.
Regulatory Submissions Specialists should focus on developing these AI-resistant skills: Critical thinking, Strategic planning, Communication with regulatory agencies, Complex data interpretation, Ethical judgment. These skills are harder for AI to replicate and will remain valuable as automation increases.
Based on transferable skills, regulatory submissions specialists can transition to: Regulatory Affairs Manager (50% AI risk, medium transition); Compliance Officer (50% AI risk, easy transition). These alternatives leverage existing expertise while offering different risk profiles.
Regulatory Submissions Specialists face high automation risk within 5-10 years. The pharmaceutical and biotech industries are increasingly adopting AI to accelerate drug development and streamline regulatory processes. This includes using AI for data analysis, predictive modeling, and automated report generation, leading to increased efficiency and reduced costs.
The most automatable tasks for regulatory submissions specialists include: Prepare and compile regulatory submissions to various health authorities (e.g., FDA, EMA) (30% automation risk); Maintain up-to-date knowledge of regulatory requirements and guidelines (40% automation risk); Review and interpret scientific data to ensure compliance with regulatory standards (35% automation risk). LLMs can assist in drafting sections of submissions and RPA can automate data compilation, but human oversight is needed for accuracy and strategic decision-making.
Explore AI displacement risk for similar roles
Legal
Career transition option | similar risk level
AI is poised to significantly impact compliance officers by automating routine monitoring, data analysis, and report generation. LLMs can assist in interpreting regulations and drafting compliance documents, while AI-powered tools can enhance fraud detection and risk assessment. However, tasks requiring nuanced judgment, ethical considerations, and complex investigations will remain human-centric for the foreseeable future.
Pharmaceutical
Pharmaceutical | similar risk level
AI is poised to impact cell therapy manufacturing by automating routine tasks such as environmental monitoring, documentation, and quality control. Robotics and computer vision systems can enhance precision and reduce contamination risks in cell handling. LLMs can assist with data analysis and report generation, but complex decision-making and process optimization will still require human expertise.
Pharmaceutical
Pharmaceutical | similar risk level
AI is poised to impact Clinical Packaging Specialists primarily through automation in routine tasks such as documentation, quality control, and inventory management. Computer vision systems can enhance inspection processes, while robotic systems can automate packaging and labeling. LLMs can assist with generating documentation and reports, but the specialized knowledge and regulatory compliance aspects of the role will limit full automation in the near term.
Pharmaceutical
Pharmaceutical | similar risk level
AI is poised to impact Clinical Pharmacovigilance Managers by automating data entry, signal detection, and report generation. LLMs can assist in literature reviews and report writing, while machine learning algorithms can improve signal detection from large datasets. However, tasks requiring critical thinking, complex decision-making regarding patient safety, and regulatory interactions will remain human-centric.
Pharmaceutical
Pharmaceutical | similar risk level
AI is poised to significantly impact drug discovery chemists by automating routine tasks such as data analysis, literature review, and compound design. Machine learning models can predict molecular properties and screen virtual compound libraries, accelerating the identification of potential drug candidates. LLMs can assist in report writing and grant proposal generation. Computer vision can automate high-throughput screening.
Pharmaceutical
Pharmaceutical | similar risk level
AI is poised to impact Drug Product Scientists by automating routine data analysis, experimental design, and report generation. LLMs can assist in literature reviews and regulatory document preparation, while machine learning algorithms can optimize formulations and predict stability. Robotics and automated systems will increasingly handle routine lab tasks.